LCK, one of the core of LUAD pivotal genes, is an independent predictor of recurrence-free and overall survival in lung cancer patients (Chen et al., 2007), which can coordinate the tumor microenvironment with CD3E to promote immunotherapy response and survival in patients with muscle-invasive bladder cancer (Zheng et al., 2021). The gene discussed is LCK; the disease is neoplasm.